{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:50:00Z","timestamp":1763016600575},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1053\/j.seminoncol.2003.11.040","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T08:58:14Z","timestamp":1131008294000},"page":"76-83","source":"Crossref","is-referenced-by-count":45,"special_numbering":"S18","title":["The effect of oral mucositis on morbidity and mortality in bone marrow transplant"],"prefix":"10.1053","volume":"30","author":[{"given":"Don A","family":"Gabriel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Shea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oludamilola","family":"Olajida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan S","family":"Serody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrance","family":"Comeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2003.11.040_BIB1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bmt.1703776","article-title":"Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation","volume":"31","author":"Filicko","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/15258160151134881","article-title":"Colony-stimulating factors in stem cell transplantation","volume":"10","author":"Godder","year":"2001","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB3","first-page":"272","article-title":"Oral mucositis in myelosuppressive cancer therapy","volume":"88","author":"Epstein","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00001622-199507000-00005","article-title":"Oral complications of local and systemic cancer treatment","volume":"7","author":"Carl","year":"1995","journal-title":"Curr Opin Oncol"},{"issue":"suppl 19","key":"10.1053\/j.seminoncol.2003.11.040_BIB5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/sonc.2002.37367","article-title":"The potential of amifostine in high-dose chemotherapy and autologous hematopoietic stem cell transplantation","volume":"29","author":"Phillips","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB6","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1200\/JCO.2001.19.8.2201","article-title":"Oral mucositis and the clinical and economic outcomes of hematopoietic stem cell transplantation","volume":"19","author":"Sonis","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1081\/CNV-100000145","article-title":"Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer","volume":"19","author":"Bennett","year":"2001","journal-title":"Cancer Invest"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1086\/313591","article-title":"Outbreak of stenotrophomonas maltophilia bacteremia in allogeneic bone marrow transplant patients","volume":"30","author":"Labarca","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1085-5629(97)80015-6","article-title":"Oral cavity complications of bone marrow transplantation","volume":"16","author":"Eisen","year":"1997","journal-title":"Semin Cutan Med Surg"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1083-8791(03)00204-0","volume":"9","author":"Shea","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB11","first-page":"1493","article-title":"Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation","volume":"20","author":"McGuire","year":"2003","journal-title":"Oncol Nurs Forum"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB12","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/1097-0142(19930901)72:5<1612::AID-CNCR2820720520>3.0.CO;2-Q","article-title":"A longitudinal study of oral uncreative mucositis in bone marrow transplant recipients","volume":"72","author":"Woo","year":"1993","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1365-2141.2000.02202.x","article-title":"Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue","volume":"110","author":"Wardley","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00002820-199812000-00002","article-title":"Acute oral pain and mucositis in bone marrow transplant and leukemia patients","volume":"21","author":"McGuire","year":"1998","journal-title":"Cancer Nurs"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB15","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1081\/CNV-120005902","article-title":"The 20 item oral mucositis index","volume":"20","author":"McGuire","year":"2002","journal-title":"Cancer Invest"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1081\/CNV-120002497","article-title":"Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis","volume":"20","author":"Bellm","year":"2002","journal-title":"Cancer Invest"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1754-4505.1990.tb00795.x","article-title":"A scoring system for the quantitative evaluation of oral mucositis during bone marrow transplantation","volume":"10","author":"Walsh","year":"1990","journal-title":"Spec Care Dentist"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0964-1955(96)00026-7","article-title":"Quantitative scale of oral mucositis associated with autologous bone marrow transplantation","volume":"32B","author":"Tardieu","year":"1996","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0304-3959(94)00256-E","article-title":"The factorial structure and stability of the McGill Pain Questionnaire in patients experiencing oral mucositis following bone marrow transplant","volume":"62","author":"Donaldson","year":"1995","journal-title":"Pain"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB20","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/1097-0142(19920515)69:10<2469::AID-CNCR2820691015>3.0.CO;2-W","article-title":"Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index","volume":"69","author":"Schubert","year":"1992","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB21","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/sj.bmt.1702447","article-title":"Mucosal barrier injury: Pathology, clinical counterparts and consequences of intensive treatment for haematological malignancies: An overview","volume":"25","author":"Blijlevens","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/1024533021000037216","article-title":"Oral Mucositis","volume":"7","author":"Alvarado","year":"2002","journal-title":"Hematology"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00002018-199309030-00004","article-title":"Cancer therapy and oral mucositis. An appraisal of drug prophylaxis","volume":"9","author":"Verdi","year":"1993","journal-title":"Drug Saf"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1067\/moe.2002.126018","article-title":"The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis","volume":"94","author":"Epstein","year":"2002","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"suppl 2","key":"10.1053\/j.seminoncol.2003.11.040_BIB25","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.bmt.1702863","article-title":"Mucositis associated with stem cell transplantation","volume":"27","author":"Stiff","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1368-8375(00)00012-9","article-title":"Defining mechanisms of action of interleukin 11 on the progression of radiation-induced oral mucositis in hamsters","volume":"36","author":"Sonis","year":"2001","journal-title":"Oral Oncol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3322\/canjclin.51.5.290","article-title":"Oral mucositis complicating chemotherapy and\/or radiotherapy","volume":"51","author":"Kostler","year":"2001","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB28","first-page":"120","article-title":"Oral complications in bone marrow transplantation patients","volume":"30","author":"Garfunkel","year":"1994","journal-title":"Isr J Med Sci"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/322595","article-title":"Risk factors for anaerobic bloodstream infections in bone marrow transplant recipients","volume":"33","author":"Lark","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB30","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2275::AID-CNCR25>3.0.CO;2-Q","article-title":"The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies","volume":"82","author":"Ruescher","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/00365549309169668","article-title":"Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteremia in allogeneic bone marrow transplant recipients","volume":"25","author":"Donnelly","year":"1993","journal-title":"Scand J Infect Dis"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0163-4453(97)91545-0","article-title":"Changes in the oral streptococcal flora of children undergoing allogeneic bone marrow transplantation","volume":"35","author":"Lucas","year":"1997","journal-title":"J Infect"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0002-9343(90)90373-L","article-title":"Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis","volume":"89","author":"Classen","year":"1990","journal-title":"Am J Med"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB34","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1200\/JCO.1999.17.8.2446","article-title":"Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants","volume":"17","author":"Rapport","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB35","first-page":"997","article-title":"Epiglottitis following preparation for allogeneic bone marrow transplantation","volume":"15","author":"Murray","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB36","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0030-4220(94)90173-2","article-title":"Intraoral pyogenic granuloma after allogeneic bone marrow transplant. Report of three cases","volume":"78","author":"Lee","year":"1994","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0964-1955(94)90059-0","article-title":"Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation","volume":"30B","author":"Borowski","year":"1994","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bmt.1703870","article-title":"A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation","volume":"31","author":"Papas","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/104454702320901107","article-title":"NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients","volume":"20","author":"Whelan","year":"2002","journal-title":"J Clin Laser Med Surg"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB40","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0360-3016(97)00076-X","article-title":"Low energy helium-neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant","volume":"38","author":"Cowen","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB41","first-page":"171","article-title":"Helium-Neon laser treatment transforms fibroblast into myofibroblast","volume":"137","author":"Pourreau-Schneider","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.bmt.1703394","article-title":"A phase I\/II double-blind, placebo-controlled study of recombinant human interleukin 11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation","volume":"29","author":"Antin","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB43","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1023\/A:1011119721267","article-title":"Prevention of mucositis in bone marrow transplantation","volume":"12","author":"Castanga","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/014860710002400261","article-title":"Effect of oral glutamine supplementation during bone marrow transplantation","volume":"24","author":"Coghlin-Dickson","year":"2000","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB45","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1079-2104(99)70034-X","article-title":"GM-CSF mouthrinses in the treatment of severe oral mucositis","volume":"88","author":"Bez","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1601-0825.1997.tb00049.x","article-title":"The use of tretinoin as oral mucositis prophylaxis in bone marrow transplantation patients","volume":"3","author":"Cohen","year":"1997","journal-title":"Oral Dis"},{"issue":"suppl 2","key":"10.1053\/j.seminoncol.2003.11.040_BIB47","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000067146","article-title":"Radioprotectants","volume":"63","author":"Gardina","year":"2002","journal-title":"Oncology"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB48","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1200\/JCO.2000.18.19.3339","article-title":"Phase III randomized trial of amifostine as a radioprotector of the head and neck","volume":"18","author":"Bizel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB49","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0360-3016(00)00768-9","article-title":"Protective effect of amifostine on dental health after radiotherapy of the head and neck","volume":"48","author":"Rudat","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB50","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0360-3016(01)02683-9","article-title":"Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer","volume":"52","author":"Antonadou","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB51","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0360-3016(00)00735-5","article-title":"Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer","volume":"48","author":"Wasserman","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB52","first-page":"3","article-title":"The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine","volume":"26","author":"Capizzi","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB53","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1083-8791(03)00204-0","article-title":"An expanded phase I\/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies","volume":"9","author":"Shea","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB54","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-2141.2000.02149.x","article-title":"Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant","volume":"110","author":"Capelli","year":"2000","journal-title":"Br J Haematol"},{"issue":"suppl 19","key":"10.1053\/j.seminoncol.2003.11.040_BIB55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/sonc.2002.37367","article-title":"The potential of amifostine in high-dose chemotherapy and autologous hematopoietic stem cell transplantation","volume":"29","author":"Phillips","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB56","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bmt.1703757","article-title":"Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma","volume":"30","author":"Thieblemont","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB57","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1054\/bjoc.2000.1611","article-title":"A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantation","volume":"84","author":"Hatrmann","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB58","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00000421-200008000-00019","article-title":"Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation","volume":"23","author":"Chauncey","year":"2000","journal-title":"Am J Clin Oncol"},{"issue":"suppl 19","key":"10.1053\/j.seminoncol.2003.11.040_BIB59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/sonc.2002.37358","article-title":"Improved tolerability of amifostine with rapid infusion and optimal patient preparation","volume":"29","author":"Bocca","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB60","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1517\/13543784.11.8.1161","article-title":"Iseganan HCl","volume":"11","author":"Giles","year":"2002","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/019262339902700113","article-title":"Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor","volume":"27","author":"Danilenko","year":"1999","journal-title":"Toxicol Pathol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB62","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00280-002-0493-8","article-title":"In vitro and in vivo effects of repifermin (keratinocyte growth factor-2, KGF-2) on human carcinoma cells","volume":"50","author":"Anderson","year":"2002","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB63","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1200\/JCO.2003.10.079","article-title":"Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy","volume":"21","author":"Meropol","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.11.040_BIB64","article-title":"Use of recombinant keratinocyte growth factor (rHuKGF) can reduce severe oral mucositis in patients with hematologic malignancies undergoing autologous peripheral blood progenitor cell transplantation (auto-PBPCT) after radiation-based conditioning","volume":"22","author":"Spielberger","year":"2003","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775403006080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775403006080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:03:55Z","timestamp":1554336235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775403006080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":64,"alternative-id":["S0093775403006080"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2003.11.040","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}